It’s a question everyone is asking. How can we get some of that "stuff" going on in Silicon Valley over in our own neck of the woods? The thriving innovation, the entrepreneurship, the technology, the money.
For starters, I recommend you watch a presentation by a fellow well known around Silicon Valley, but new to me: Steve Blank and his talk, The Secret History of Silicon Valley.
In a first of its kind, a new incubator modeled on the well known Y Combinator has been started for emerging synthetic biology companies. SynBio Launchpad is a joint effort by Singularity University, provider of higher education in exponentially advancing industries, and their landlord, NASA. The program came about from a discussion between Andrew Hessel, co-chair of SU’s Biotechnology and Bioinformatics track, and John Cumbers, Deputy Managing Director of Synthetic Biology at NASA.
This podcast originally aired on April 3, 2012
Podcast Sponsor: Audacity - Building health and science brand supremacy through disruptive marketing and advertising. Download "4 Secrets to Brand Supremacy," for free www.audacityhealth.com/approach
Guest:
Atul Butte, MD,PhD, Associate Professor of Pediatrics, Medicine, and Computer Science, Stanford Bio and Contact Info
Listen (0:58) How did you get to the center of the bioinformatics universe?
Listen (2:06) 99% of our work is coming up with great questions
Listen (1:59) When will we have a new molecular based classification for disease?
Listen (2:54) What are you most passionate about?
Listen (3:45) iPOP - Integrated Personal Omics Profiling
Listen (2:07) Biggest challenge to clinical sequencing
Listen (1:57) Bioinformatician - the new hybrid
Listen (6:05) Thoughts on entrepreneurship
Listen (2:22) The dry researcher
Listen (3:32) Looking ahead
As part of our series, 'Finding Meaning in the Data,' we’re pleased to have Dr. Atul Butte to the program. He is Chief of the Division of Systems Medicine and Associate Professor of Pediatrics, Medicine, and Computer Science, at Stanford University and Lucile Packard Children's Hospital. The Butte Lab at Stanford has received a good amount of press as one of the leading labs worldwide focused on converting billions of molecular and clinical data into meaningful new insights into disease. Atul trained in Computer Science and received an MD at Brown University, worked as a software engineer at Apple and Microsoft, trained in Pediatrics at Children's Hospital Boston, then received his PhD in Health Sciences and Technology from Harvard Medical School and MIT. He’s the co-founder and scientific advisor to several start-ups, including NuMedii and Personalis.
Podcast Sponsor: Chempetitive Group - Adding "life" to life science marketing
Guest:
Rowan Chapman, Mohr Davidow Bio and Contact Info
Listen (3:35) I've got a PhD, what next?
Listen (5:38) How did you become an investor?
Listen (6:14) Mohr Davidow investing in industry intersections
Listen (3:58) What can you tell start-ups about approaching VC?
Listen (4:17) Trends in life science funding
Listen (4:20) What hot spots excite you today?
Rowan Chapman is a partner at the VC firm, Mohr Davidow, and first dedicated member of the team devoted to life science. Rowan says she has a passion to work with entrepreneurs in a "hands on" role to help get companies started and financed. She’s a board member of four companies including Sequenta, VitaPath Genetics, and Health Tap and a board observer at Cardio Dx and Tethys Bioscience. Prior to that she worked closely with the board for PacBio, Paralelle, and RainDance. She has her finger on things all the way from tools, to social media, to diagnostics, to therapeutics. She is also a member of the Personalized Medicine Coalition. Prior to joining Mohr Davidow, Rowan held the position of director of business development at Rosetta Inpharmatics (acquired by Merck) We’re very happy to have her join us to talk about the investment side of the industry.
© 2023 de novo productions · Privacy · Terms· Underwriting · Contact
